RecruitingNCT07636590

Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency

A Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency


Sponsor

Claris Biotherapeutics, Inc.

Enrollment

500 participants

Start Date

May 22, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).


Eligibility

Min Age: 12 YearsMax Age: 99 Years

Inclusion Criteria4

  • A photopic BCVA in the prospective study eye(s) of ≤ 70 letters at the Screening and Day 1 visits AND a change of ≤ 10 letters in photopic BCVA at Day 1 compared to the Screening Visit
  • Qualifying LSCD diagnosis in the study eye(s) prior to enrollment at Day 1
  • Written confirmation that exclusions on retinal findings are met in the study eye(s) prior to enrollment at Day 1
  • Inflammation associated with LSCD or other non-infectious inflammation (e.g., dry eye, ocular rosacea, and blepharitis) that will not interfere with the subject's participation in the opinion of the investigator is permitted.

Exclusion Criteria3

  • Any active ocular infection in either eye at either the Screening or Day 1 visits
  • Active sterile iritis or uveitis in either eye at Screening or Day 1 visits
  • Screening visit retinal exam finding, in the opinion of the investigator, that would limit potential for visual acuity gain in the study eye(s)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon-interventional

Non-interventional


Locations(2)

Midwest Cornea Associates, LLC

Carmel, Indiana, United States

Francis Price Jr, MD

Indianapolis, Indiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07636590


Related Trials